Structures by: Patra M.
Total: 27
C23H22FeN2O2
C23H22FeN2O2
Journal of medicinal chemistry (2012) 55, 20 8790-8798
a=22.5840(5)Å b=7.59176(18)Å c=10.5047(3)Å
α=90.00° β=92.039(2)° γ=90.00°
C23H24FeN2O
C23H24FeN2O
Journal of medicinal chemistry (2012) 55, 20 8790-8798
a=7.4550(2)Å b=10.3389(2)Å c=13.2992(3)Å
α=72.296(2)° β=81.3454(19)° γ=78.354(2)°
C25H26FeN2O2
C25H26FeN2O2
Journal of medicinal chemistry (2012) 55, 20 8790-8798
a=19.7267(7)Å b=5.7377(2)Å c=36.2680(11)Å
α=90.00° β=90.00° γ=90.00°
Rhodamine-B-hydrazone of isophthalaldehyde
C64H66N8O4
RSC Adv. (2015)
a=20.2211(17)Å b=95.380(9)Å c=12.5142(10)Å
α=90° β=90° γ=90°
C23H18F3FeN3O2
C23H18F3FeN3O2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 44 17662-17671
a=9.2568(5)Å b=9.9157(5)Å c=12.7041(4)Å
α=80.988(4)° β=89.238(4)° γ=67.841(5)°
C15H16FeN2O2
C15H16FeN2O2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 44 17662-17671
a=11.5070(6)Å b=10.0116(6)Å c=12.1955(6)Å
α=90° β=104.607(5)° γ=90°
C26H26Fe2N2O2
C26H26Fe2N2O2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 44 17662-17671
a=9.979(4)Å b=15.213(2)Å c=15.324(4)Å
α=77.265(4)° β=84.485(7)° γ=89.500(13)°
C18H17Cl3CrN0O6
C18H17Cl3CrN0O6
Dalton transactions (Cambridge, England : 2003) (2012) 41, 1 112-117
a=6.544(11)Å b=10.621(19)Å c=14.77(3)Å
α=88.23(5)° β=82.95(3)° γ=87.18(5)°
C18H15F6N3O3PRe
C18H15F6N3O3PRe
Dalton transactions (Cambridge, England : 2003) (2010) 39, 24 5617-5619
a=7.852(4)Å b=10.081(5)Å c=26.274(13)Å
α=90.00° β=90.00° γ=90.00°
C42H35BN3O3Re
C42H35BN3O3Re
Dalton transactions (Cambridge, England : 2003) (2010) 39, 24 5617-5619
a=9.135(4)Å b=12.789(6)Å c=19.230(9)Å
α=108.477(9)° β=91.253(10)° γ=101.914(9)°
C17H20FeO5
C17H20FeO5
Organometallics (2010) 29, 19 4312
a=7.3880(15)Å b=13.210(3)Å c=16.460(3)Å
α=90.00° β=91.78(3)° γ=90.00°
C27H26Fe2O4
C27H26Fe2O4
Organometallics (2010) 29, 19 4312
a=11.610(6)Å b=12.633(6)Å c=17.403(8)Å
α=109.481(10)° β=95.275(10)° γ=108.598(9)°
C26H24Fe2N0O4
C26H24Fe2N0O4
Organometallics (2010) 29, 19 4312
a=15.826(3)Å b=10.417(2)Å c=12.881(3)Å
α=90.00° β=92.109(6)° γ=90.00°
C27H26Fe2O4
C27H26Fe2O4
Organometallics (2010) 29, 19 4312
a=12.285(5)Å b=12.365(5)Å c=16.608(7)Å
α=69.725(8)° β=71.668(9)° γ=72.633(9)°
C17H16CrN0O6
C17H16CrN0O6
Dalton transactions (Cambridge, England : 2003) (2012) 41, 1 112-117
a=8.523(19)Å b=12.07(2)Å c=15.87(3)Å
α=90.00° β=100.22(2)° γ=90.00°
C28H28Fe2O4
C28H28Fe2O4
Organometallics (2010) 29, 19 4312
a=13.714(14)Å b=12.304(12)Å c=14.015(14)Å
α=90.00° β=97.30(2)° γ=90.00°
C20H18F3FeNO2S
C20H18F3FeNO2S
Organometallics (2016) 35, 19 3369
a=12.8050(4)Å b=6.9160(2)Å c=21.7943(7)Å
α=90° β=97.946(3)° γ=90°
C40H34F6Fe2N2O3S2
C40H34F6Fe2N2O3S2
Organometallics (2016) 35, 19 3369
a=10.6747(4)Å b=13.1639(5)Å c=14.6246(6)Å
α=108.022(3)° β=91.905(3)° γ=103.904(3)°
C12H16ClFeNO
C12H16ClFeNO
Organometallics (2016) 35, 19 3369
a=13.8639(5)Å b=19.0344(6)Å c=9.5549(3)Å
α=90° β=93.220(3)° γ=90°
C19H19FeNS
C19H19FeNS
Organometallics (2013) 32, 20 6098
a=23.4053(8)Å b=23.4053(8)Å c=5.8962(4)Å
α=90.00° β=90.00° γ=90.00°
C20H21FeNOS
C20H21FeNOS
Organometallics (2013) 32, 20 6098
a=14.0176(10)Å b=5.8275(3)Å c=22.0395(13)Å
α=90.00° β=106.018(6)° γ=90.00°
C19H20FeN2S
C19H20FeN2S
Organometallics (2013) 32, 20 6098
a=19.18773(17)Å b=9.31430(9)Å c=9.21247(8)Å
α=90.00° β=94.5062(8)° γ=90.00°
C18H17FeNOS
C18H17FeNOS
Organometallics (2013) 32, 20 6098
a=13.1758(2)Å b=13.5806(3)Å c=8.7585(2)Å
α=90.00° β=90.00° γ=90.00°
C16H16Fe0MnNO5
C16H16Fe0MnNO5
Organometallics (2012) 31, 16 5760
a=7.996(4)Å b=23.664(11)Å c=9.514(5)Å
α=90.00° β=113.750(5)° γ=90.00°
C24H24MnNO11
C24H24MnNO11
Organometallics (2012) 31, 16 5760
a=21.472(10)Å b=7.707(3)Å c=30.064(14)Å
α=90.00° β=90.00° γ=90.00°
C23H20MnNO9
C23H20MnNO9
Organometallics (2012) 31, 16 5760
a=7.727(11)Å b=9.545(15)Å c=16.53(3)Å
α=82.10(4)° β=86.75(5)° γ=67.37(4)°
C29H35FeNO6Si
C29H35FeNO6Si
Organometallics (2012) 31, 16 5760
a=30.07(4)Å b=7.5683(10)Å c=13.092(18)Å
α=90.00° β=102.270(16)° γ=90.00°